Clinical management of patients with ASXL1 mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillance

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 9, 2015-09 ,pp. : 2122-2131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mid1/Mid2 expression in craniofacial development and a literature review of X‐linked opitz syndrome

By  

Molecular Genetics & Genomic Medicine, Vol. 4, Iss. 1, 2016-01 ,pp. : 95-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome

By Cox Timothy C.  

Human Molecular Genetics, Vol. 9, Iss. 17, 2000-10 ,pp. : 2553-2562

Oxford University Press

Access to resources Recommend Favorite

Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith–Lemli–Opitz syndrome

By Kelley R.I.  

Human Molecular Genetics, Vol. 10, Iss. 6, 2001-03 ,pp. : 555-564

Oxford University Press

Access to resources Recommend Favorite

Molecular diagnostics of Meckel–Gruber syndrome highlights phenotypic differences between MKS1 and MKS3

By Consugar Mark   Kubly Vickie   Lager Donna   Hommerding Cynthia   Wong Wai   Bakker Egbert   Gattone Vincent   Torres Vicente   Breuning Martijn   Harris Peter  

Human Genetics, Vol. 121, Iss. 5, 2007-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite